RXST
NASDAQ HealthcareRxSight, Inc. - Common Stock
Medical Devices
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is headquartered in Aliso Viejo, California.
�� 市场数据
| 价格 | $7.61 |
|---|---|
| 成交量 | 596,368 |
| 市值 | 314.04M |
| 贝塔系数 | 1.210 |
| RSI（14日） | 70.3 超买 |
| 200日均线 | $8.91 |
| 50日均线 | $7.46 |
| 52周最高 | $16.74 |
| 52周最低 | $5.90 |
| Forward P/E | -15.77 |
| Price / Book | 1.14 |
🎯 投资策略评分
RXST 在各投资策略中的评分。分数越高，越符合该策略目标。
🔍 策略解读
最佳匹配： 🔪 Falling Knife (77/100) — 此策略 逆向投资（超卖 + 低于移动均线）.
评分最低的策略： 🐋 Institutional Whale (7/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →
📚 了解更多
在文本中查找 RXST in your text
粘贴任何文章、记录或帖子 — 工具将提取 RXST 以及每一个其他隐藏的股票代码。
免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-04-17.